Valuation: Cegedim

Market Cap 140M 160M 130M 120M 225M 15.25B 229M 1.55B 606M 7.56B 599M 586M 26.12B P/E 2026 *
6.69x
P/E 2027 * 5.1x
Enterprise Value 302M 344M 281M 259M 485M 32.9B 494M 3.34B 1.31B 16.32B 1.29B 1.26B 56.37B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 158M
+0.05%-1.17%-51.06%+3.06% 345B
+5.26%+15.17%-35.00%+29.15% 199B
+4.79%+5.65%-42.91%-1.21% 109B
+6.45%+13.61%-37.63%+8.43% 42.61B
-2.52%-5.68%-76.19%+121.26% 35.43B
+4.35%+5.73%-12.81%+62.89% 29.7B
+4.86%+4.83%-33.59%+52.12% 17.88B
+4.68%+12.59%-31.37%+10.01% 13B
+6.78%+6.84%-28.64%+98.09% 12.43B
Average +3.40%+2.01%-38.80%+42.64% 89.35B
Weighted average by Cap. +2.37%+2.19%-43.92%+19.30%

Financials

2026 *2027 *
Net sales 660M 752M 614M 565M 1.06B 71.8B 1.08B 7.29B 2.85B 35.61B 2.82B 2.76B 123B 684M 779M 637M 586M 1.1B 74.47B 1.12B 7.56B 2.96B 36.93B 2.93B 2.86B 128B
Net income 21.3M 24.27M 19.83M 18.24M 34.2M 2.32B 34.78M 235M 92.11M 1.15B 91.12M 89.15M 3.97B 28M 31.91M 26.07M 23.98M 44.96M 3.05B 45.73M 309M 121M 1.51B 120M 117M 5.22B
Net Debt 162M 185M 151M 139M 260M 17.65B 265M 1.79B 701M 8.75B 694M 679M 30.25B 134M 152M 125M 115M 215M 14.56B 218M 1.48B 578M 7.22B 572M 560M 24.95B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-